Abstract: The present invention relates to an improved device for supplying temperature controlled laminar air flow (TLA) of filtered air to generate a clean air zone, e.g. a controlled personal breathing zone, at a point of care. The specific relative placement of the air inlets and outlets of the device of the present invention enables the provision of a more stable TLA based clean air zone than the prior art devices and at the same time allows for extensive monitoring and reporting features.

Abstract: The present invention provides a practical method for treating atopic dermatitis. By subjecting patients suffering from atopic dermatitis to filtered temperature controlled laminer air flow disease symptoms have been significantly reduced and even removed. The velocity of the laminar air flow is balanced such that body convections are braked without the generation of draught..

Abstract: This invention relates in general to methods and devices for displacing body convection and thereby reducing exposure to allergens and other airborne fine particles within a personal breathing zone during situations of or corresponding to sleep thereby reducing or removing symptoms of asthma and allergic rhinitis while improving quality of sleep and in particular to methods and devices that utilize Temperature controlled Laminar Airflow (abbreviated TLA from herein and onwards). Also, business methods involving such methods and devices are disclosed.

Abstract: Provided are methods and devices for improving microvascular function in humans and mammals. Reduction of exposure to airborne fine particles using air treatment systems increases microvascular function in persons at cardiovascular risk. Preferred treatment systems provide a zone of clean air having >75% reduction in airborne particle counts around a person at cardiovascular risk. The devices and methods can be optimally used during sleep, when the user is stationary for an extended period.

Abstract: This invention relates in general to methods and devices for displacing body convection and thereby reducing exposure to allergens and other airborne fine particles within a personal breathing zone during situations of or corresponding to sleep thereby reducing or removing symptoms of asthma and allergic rhinitis while improving quality of sleep and in particular to methods and devices that utilize Temperature controlled Laminar Airflow (abbreviated TLA from herein and onwards). Also, business methods involving such methods and devices are disclosed.

Abstract: Methods and devices are provided whereby a controlled personal breathing zone is maintained using temperature controlled laminar air flow (TLA) of filtered air. A substantially laminar, descending flow of filtered air is maintained with a velocity determined by the air-temperature difference between the supplied air and the ambient air t at the level of the personal breathing zone. The air-temperature of the filtered supply air can be carefully adjusted to maintain the velocity-determining difference in air-temperature within the optimum range of 0.3 to 1° C. Thus being able to at the same time displace body convection and achieve comfort.

Abstract: The present invention relates to a method and a device for providing a zone (2) of clean air at an operation area (3) wherein an air treatment device (1) having a lighting device (25) is brought to a functional position such that the air treatment device (1) and the lighting device (25) are located above an operation area (3) and between the operation area (3) and a ceiling (32) in the operation premises (4). Air is taken into the air treatment device (1) from upper portions of the operation premises (4) and subsequently filtered in the air treatment device (1). The air is cooled in the air treatment device (1) to achieve a lower temperature than impure air (8) surrounding the zone (2) of clean air and subsequently discharged from the air treatment device (1) as a laminar air flow descending slowly downwards towards the operation area (3).

Abstract: Provided are methods for ventilating a surgical theater using temperature-regulated laminar air flow. Velocity of a downward directed laminar clean air flow is determined by an air-temperature difference between the supply air and room air temperature at the level of the operating table. Room air temperature at the level of the operating table is measured and clean supply air temperature controlled in relation to this measurement. In order to maintain a constant downward directed laminar clean air flow velocity, a constant difference in temperature is maintained between room air temperature at the level of the operating table and the lower temperature of the supply air. In preferred embodiments, this constant temperature difference provides a downward directed air flow velocity of at least 0.25 m/s and is maintained in part by minimizing fluctuations in ambient air-temperature through use of air supply units supplying heated or cooled air outside the clean air zone.

Abstract: Provided are methods and devices for improving microvascular function in humans and mammals. Reduction of exposure to airbourne fine particles using air treatment systems increases microvascular function in persons at cardiovascular risk. Preferred treatment systems provide a zone of clean air having >75% reduction in airbourne particle counts around a person at cardiovascular risk. The devices and methods can be optimally used during sleep, when the user is stationary for an extended period.